tradmap

PRQR ProQR Therapeutics N.V.

$1.37 +4.58%

Data as of close

Healthcare · Pharmaceutical Preparations

ProQR Therapeutics N.V. (PRQR) is a healthcare company in the Pharmaceutical Preparations industry, with a market capitalization of $144 million. Shares last traded at $1.37, 51.1% below their 52-week high. Over the past year the stock is down 49.9%.

Market Cap
$144M
Shares Out
105.4M
EPS (TTM)
—
P/E (TTM)*
—
P/S Ratio
—
P/B Ratio
—
Dividend / Share
—
Dividend Yield
—
52-Week High
$2.80
52-Week Low
$1.20
Volume (venue)
24,952
Avg Vol (3m, venue)
52,968.333

* P/E (TTM) = market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year — the same basis as the peer table and the screener, so it can differ from price ÷ EPS.

ProQR Therapeutics N.V. reports in EUR: EPS, dividends and financials are shown in EUR as filed. P/E, P/S, P/B and yield convert them at 1 EUR = 1.1163 USD on 2026-10-30 (Federal Reserve H.10 via FRED, DEXUSEU).

Performance

1W
+2.24%
1M
-17.47%
3M
-30.46%
6M
-16.97%
YTD
-31.84%
1Y
-49.91%

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)
41.38
SMA (50)
$1.71
SMA (200)
$1.69
Price vs SMA50
-19.99%
Price vs SMA200
-18.88%
ATR (14)
$0.09

Full technical analysis (26 indicators, D/W/M) →

Pharmaceutical Preparations peers

PRQR vs 14 industry peers (Pharmaceutical Preparations), by market cap. Data as of close

1–14 of 14
LLYLilly (Eli)$1.33T48.0715.3331.9%-0.12%
JNJJohnson & Johnson$640.8B39.816.4516.2%-1.76%
ONCBeone Medicines Ltd.$524.6B800.0585.5910.7%-1.72%
ABBVAbbVie$503.8B48.717.6315.7%-1.30%
MRKMerck$356.9B112.495.364.8%-2.57%
ABTAbbott Laboratories$190.6B30.374.2213.9%-0.78%
PFEPfizer$171.2B42.462.696.3%-2.18%
VRTXVertex Pharmaceuticals$134.7B33.8710.4030.7%-6.81%
BMYBristol Myers Squibb$126.1B13.652.5218.5%-2.09%
REGNRegeneron Pharmaceuticals$100.7B20.915.9628.5%+1.30%
TEVATeva Pharmaceutical Industries Ltd$48.9B96.622.842.9%+3.00%
ZTSZoetis$34.3B13.113.6027.5%-0.18%
RPRXRoyalty Pharma Plc$29.5B36.2511.6532.1%-0.26%
ROIVRoivant Sciences Ltd.$26.0B—3458.17—+0.47%

Source: SEC EDGAR (fundamentals/EPS/dividends, reported in EUR) · Databento EQUS.MINI (prices) · FX: 1 EUR = 1.1163 USD on 2026-10-30 (Federal Reserve H.10 via FRED, DEXUSEU) · market cap & yield computed by tradmap. This product uses the FRED® API but is not endorsed or certified by the Federal Reserve Bank of St. Louis. Informational only — not financial advice.